Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.23853 ↗At a glance
Journal article in Molecular Carcinogenesis, 2025. Written by Ying-Peng Peng and 7 co-authors. Institution: The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Major MEDLINE topics: Nasopharyngeal Carcinoma, Brain Neoplasms, Nasopharyngeal Neoplasms, Biomarkers, Tumor. Cited 2 times so far (Crossref); 31 references. Funded by: This study was funded by Guangdong Medical Research Foundation (Grant No. A2024251)..
Abstract (original language)
Brain metastasis in nasopharyngeal carcinoma is a rare but poor prognosis clinical problem. This study aims to investigate the clinical characteristics and identify the genomic profiling of nasopharyngeal carcinoma brain metastasis. Patients with a diagnosis of nasopharyngeal carcinoma who visited at the Fifth Affiliated Hospital of Sun Yat‐sen University since January 2013 to December 2023 were retrospectively collected. Clinical data of patients diagnosed with nasopharyngeal carcinoma brain metastasis were extracted. Paraffin blocks of NPC brain metastases were acquired for immunohistochemistry and genetic testing. High‐throughput second generation sequencing was performed for genomic analysis. The mutation landscape was further analyzed. Of the 2378 NPC patients from our database, only six were clinically diagnosed with nasopharyngeal carcinoma brain metastasis. Three were pathologically diagnosed with nasopharyngeal carcinoma brain metastasis. The time interval from the first diagnosis of nasopharyngeal carcinoma to brain metastasis was 15–56 months. The common sites of brain metastasis were frontal lobe and cerebellum, and could be single or multiple, cystic or solid lesions. The OS ranged from 7 to 48 months. Single nucleotide variants were found in 32 genes, such as PTEN, TP53, NFKBIA, KMT2C, and NOTCH1. Copy number variation occurred in five genes, including PTEN, CCDN1, FGF19, FGF3 and FGF4. PTEN and fibroblast growth factors might be involved in the molecular regulation of brain metastasis in nasopharyngeal carcinoma.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
- Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
- Department of Radiotherapy and Minimally Invasive Surgery, The Cancer Center of The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
- Department of Pathology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
- Department of Neurosurgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
ORCID profiles: Ying-Peng Peng
Funding
- This study was funded by Guangdong Medical Research Foundation (Grant No. A2024251).
Cite
APA
Peng, Y. P., Yang, S., He, J., Liu, Q., Li, X., Kong, F. G., Wang, S. Y., & Liu, Y. (2025). Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23853
Vancouver
Peng YP, Yang S, He J, Liu Q, Li X, Kong FG, et al. Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23853
BibTeX
@article{Peng2025,
author = {Peng, Ying-Peng and Yang, Shuai and He, Jianzhong and Liu, Qiaodan and Li, Xuanzi and Kong, Fan-Gen and Wang, Si-Yang and Liu, Ye},
title = {Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.23853}
}
EUVIMED